Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with liver cirrhosis

Jihyun An, Hyung-Don Kim, Seon-Ok Kim, Ha Il Kim, Gi-Won Song, Han Chu Lee, Ju Hyun Shim

Clin Mol Hepatol. 2022;28(1):67-76. Published online October 12, 2021

DOI: https://doi.org/10.3350/cmh.2021.0202

View: 4106 Download: 169 Citations: 2

Stereotactic body radiation therapy for small (≤5 cm) hepatocellular carcinoma not amenable to curative treatment: Results of a single-arm, phase II clinical trial

Sang Min Yoon, So Yeon Kim, Young-Suk Lim, Kang Mo Kim, Ju Hyun Shim, Danbi Lee, Jihyun An, Jinhong Jung, Jong Hoon Kim, Han Chu Lee

Clin Mol Hepatol. 2020;26(4):506-515. Published online July 10, 2020

DOI: https://doi.org/10.3350/cmh.2020.0038

View: 5455 Download: 189 Citations: 42

Comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion

Danbi Lee, Han Chu Lee, Jihyun An, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Young-Hwa Chung, Yung Sang Lee

Clin Mol Hepatol. 2018;24(2):144-150. Published online January 16, 2018

DOI: https://doi.org/10.3350/cmh.2017.0041

View: 8544 Download: 170 Citations: 11

Clinical features and outcomes of patients with hepatocellular carcinoma complicated with bile duct invasion

Jihyun An, Kwang Sun Lee, Kang Mo Kim, Do Hyun Park, Sang Soo Lee, Danbi Lee, Ju Hyun Shim, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee

Clin Mol Hepatol. 2017;23(2):160-169. Published online May 16, 2017

DOI: https://doi.org/10.3350/cmh.2016.0088

View: 8161 Download: 232 Citations: 25

Case Report

A case of primary hepatic actinomycosis: an enigmatic inflammatory lesion of the liver

Yeon Jung Ha, Ji Hyun An, Ju Hyun Shim, Eun Sil Yu, Jong Jae Kim, Tae Yong Ha, Han Chu Lee

Clin Mol Hepatol. 2015;21(1):80-84. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.80

View: 7443 Download: 102 Citations: 7

Original Article

Fibroblast growth factor receptor isotype expression and its association with overall survival in patients with hepatocellular carcinoma

Hyo Jeong Lee, Hyo Jeong Kang, Kang Mo Kim, Eun Sil Yu, Ki Hun Kim, Seung-Mi Kim, Tae Won Kim, Ju Hyun Shim, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee

Clin Mol Hepatol. 2015;21(1):60-70. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.60

View: 7982 Download: 125 Citations: 20

No association between the IL28B SNP and response to peginterferon plus ribavirin combination treatment in Korean chronic hepatitis C patients

Nae-Yun Heo, Young-Suk Lim, Woochang Lee, Minkyung Oh, Jiyun An, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Han Chu Lee, Yung Sang Lee, Dong Jin Suh

Clin Mol Hepatol. 2014;20(2):177-184. Published online June 30, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.2.177

View: 6503 Download: 57 Citations: 4

Role of 15-hydroxyprostaglandin dehydrogenase down-regulation on the prognosis of hepatocellular carcinoma

Jee Eun Yang, Eunji Park, Hyo Jeong Lee, Hyo Jeong Kang, Kang Mo Kim, Eunsil Yu, Danbi Lee, Ju Hyun Shim, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee

Clin Mol Hepatol. 2014;20(1):28-37. Published online March 26, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.1.28

View: 7210 Download: 62 Citations: 2

High effectiveness of peginterferon alfa-2a plus ribavirin therapy in Korean patients with chronic hepatitis C in clinical practice

Nae-Yun Heo, Young-Suk Lim, Han Chu Lee, Yung Sang Lee, Kang Mo Kim, Kwan Soo Byun, Kwang-Hyub Han, Kwan Sik Lee, Seung Woon Paik, Seung Kew Yoon, Dong Jin Suh

Clin Mol Hepatol. 2013;19(1):60-69. Published online March 25, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.1.60

View: 8118 Download: 61 Citations: 7

Clinical and epidemiological characteristics of Korean patients with hepatitis C virus genotype 6

Mun Hyuk Seong, Ho Kil, Jong Yeop Kim, Sang Soo Lee, Eun Sun Jang, Jin-Wook Kim, Sook-Hyang Jeong, Young Seok Kim, Si Hyun Bae, Youn Jae Lee, Han Chu Lee, Haesun Yun, Byung Hak Kang, Kisang Kim

Clin Mol Hepatol. 2013;19(1):45-50. Published online March 25, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.1.45

View: 7205 Download: 84 Citations: 12

Editorial

Noninvasive diagnostic criteria for hepatocellular carcinoma

Han Chu Lee

Clin Mol Hepatol. 2012;18(2):174-177. Published online June 26, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.2.174

View: 6050 Download: 51 Citations: 3

Case Report

Drug rash with eosinophilia and systemic symptoms syndrome following cholestatic hepatitis A: a case report

Jihyun An, Joo Ho Lee, Hyojeong Lee, Eunsil Yu, Dan Bi Lee, Ju Hyun Shim, Sunyoung Yoon, Yumi Lee, Soeun Park, Han Chu Lee

Clin Mol Hepatol. 2012;18(1):84-88. Published online March 22, 2012

DOI: https://doi.org/10.3350/kjhep.2012.18.1.84

View: 6290 Download: 53 Citations: 8

Osler-Weber-Rendu disease presenting with hepatocellular carcinoma: radiologic and genetic findings

Joo Ho Lee, Yung Sang Lee, Pyo Nyun Kim, Beom Hee Lee, Gu-Whan Kim, Han-Wook Yoo, Nae-Yun Heo, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung, Dong Jin Suh

Clin Mol Hepatol. 2011;17(4):313-318. Published online December 26, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.4.313

View: 8604 Download: 58 Citations: 6

Original Article

Applicability of the BCLC staging system to patients with hepatocellular carcinoma in Korea: analysis at a single center with a liver transplant center

Sung Eun Kim, Han Chu Lee, Kang Mo Kim, Young-Suk Lim, Young-Hwa Chung, Yung Sang Lee, Dong Jin Suh

Clin Mol Hepatol. 2011;17(2):113-119. Published online June 23, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.2.113

View: 8097 Download: 46 Citations: 24

Editorial

Liver function tests as indicators of metabolic syndrome

Han Chu Lee

Clin Mol Hepatol. 2011;17(1):9-11. Published online March 21, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.1.9

View: 5093 Download: 47 Citations: 3

Original Article

Cardiovascular Risk in Chronic Hepatitis B Patients Treated with Tenofovir Disoproxil Fumarate or Tenofovir Alafenamide

Hyeyeon Hong, Won-Mook Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Jonggi Choi

Received August 25, 2023 Accepted November 19, 2023

DOI: https://doi.org/10.3350/cmh.2023.0328 [Accepted]

View: 234 Download: 30

1 |

Viewed By 4788	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4753	Hepatitis B core-related antigen: A novel and promising surrogate biomarker to guide anti-hepatitis B virus therapy
Viewed By 3767	MAFLD: How is it different from NAFLD?
Viewed By 2613	Management of refractory ascites
Viewed By 2455	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 131	KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Cited By 78	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 60	From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
Cited By 55	Obesity and the risk of primary liver cancer: A systematic review and meta-analysis
Cited By 54	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma

Search